Cargando…

Introduction to tobacco control supplement

Electronic cigarettes (e-cigarettes) have recently gained significant attention in the marketplace and in the media. However, limited information is available about the worldwide impact of e-cigarettes; most public health officials are calling for more data so they can more fully understand the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ii-Lun, Husten, Corinne G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995278/
https://www.ncbi.nlm.nih.gov/pubmed/24732156
http://dx.doi.org/10.1136/tobaccocontrol-2013-051504
_version_ 1782312854687318016
author Chen, Ii-Lun
Husten, Corinne G
author_facet Chen, Ii-Lun
Husten, Corinne G
author_sort Chen, Ii-Lun
collection PubMed
description Electronic cigarettes (e-cigarettes) have recently gained significant attention in the marketplace and in the media. However, limited information is available about the worldwide impact of e-cigarettes; most public health officials are calling for more data so they can more fully understand the potential risks and benefits of e-cigarettes in order to inform regulatory action. In the USA, e-cigarettes that are marketed as tobacco products are not currently regulated by the Food and Drug Administration (FDA). However, having a continuum of nicotine-containing products that cross jurisdictional lines within the FDA in the future would create the potential (and the need) for a comprehensive nicotine strategy at the FDA. As part of developing the most appropriate approach to e-cigarette regulation, FDA Center for Tobacco Products scientists have been reviewing the available literature to determine the state of e-cigarette knowledge and have identified research areas that could be addressed. This supplement provides a summary of the current knowledge and research gaps pertaining to e-cigarettes with regards to product design, chemistry and toxicology of e-liquid and aerosol constituents, human factor-based risk factors, abuse liability, clinical pharmacology and human health effects, paediatric issues, and environmental issues.
format Online
Article
Text
id pubmed-3995278
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39952782014-04-25 Introduction to tobacco control supplement Chen, Ii-Lun Husten, Corinne G Tob Control Introduction Electronic cigarettes (e-cigarettes) have recently gained significant attention in the marketplace and in the media. However, limited information is available about the worldwide impact of e-cigarettes; most public health officials are calling for more data so they can more fully understand the potential risks and benefits of e-cigarettes in order to inform regulatory action. In the USA, e-cigarettes that are marketed as tobacco products are not currently regulated by the Food and Drug Administration (FDA). However, having a continuum of nicotine-containing products that cross jurisdictional lines within the FDA in the future would create the potential (and the need) for a comprehensive nicotine strategy at the FDA. As part of developing the most appropriate approach to e-cigarette regulation, FDA Center for Tobacco Products scientists have been reviewing the available literature to determine the state of e-cigarette knowledge and have identified research areas that could be addressed. This supplement provides a summary of the current knowledge and research gaps pertaining to e-cigarettes with regards to product design, chemistry and toxicology of e-liquid and aerosol constituents, human factor-based risk factors, abuse liability, clinical pharmacology and human health effects, paediatric issues, and environmental issues. BMJ Publishing Group 2014-05 /pmc/articles/PMC3995278/ /pubmed/24732156 http://dx.doi.org/10.1136/tobaccocontrol-2013-051504 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Introduction
Chen, Ii-Lun
Husten, Corinne G
Introduction to tobacco control supplement
title Introduction to tobacco control supplement
title_full Introduction to tobacco control supplement
title_fullStr Introduction to tobacco control supplement
title_full_unstemmed Introduction to tobacco control supplement
title_short Introduction to tobacco control supplement
title_sort introduction to tobacco control supplement
topic Introduction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995278/
https://www.ncbi.nlm.nih.gov/pubmed/24732156
http://dx.doi.org/10.1136/tobaccocontrol-2013-051504
work_keys_str_mv AT cheniilun introductiontotobaccocontrolsupplement
AT hustencorinneg introductiontotobaccocontrolsupplement